Diversity in Renal Function Monitoring and Dose Modifications During Treatment for Childhood Cancer: A Call for Standardization

被引：5
|
作者：
Blufpand, Hester N. [1 ]
Hes, Nicole [1 ]
Bokenkamp, Arend [1 ]
van de Wetering, Marianne D. [2 ]
Kaspers, Gertjan J. L. [1 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, NL-1081 HV Amsterdam, Netherlands
[2] Emma Childrens Hosp, Acad Med Ctr, Amsterdam, Netherlands
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷 / 02期
关键词：
adverse effects; chemotherapy induced nephrotoxicity; childhood cancer; dose modifications in case of renal dysfunction; renal function; IFOSFAMIDE-INDUCED NEPHROTOXICITY; GLOMERULAR-FILTRATION-RATE; CYSTATIN-C; SERUM CREATININE; SARCOMA PATIENTS; KIDNEY-FUNCTION; RISK-FACTORS; CHILDREN; SURVIVORS; CARBOPLATIN;
D O I：
10.1002/pbc.24572
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Despite changes in survival and drug tolerability, nephrotoxicity remains an important complication of chemotherapy. To provide cutting-edge care for children with cancer oncologist must be familiar with their nephrotoxic potential. Careful monitoring of renal function during treatment is therefore indicated. Well-defined guidelines for this are lacking. We reviewed current DCOG protocols and showed that monitoring of renal function during treatment varies widely between protocols. In some protocols recommended renal function measures are inappropriate given the chemotherapy prescribed. Advices on dose modifications in case of renal dysfunction also vary, even with comparable regimens. These differences are unwanted and call for standardization. Pediatr Blood Cancer 2014;61:337-344. (c) 2013 Wiley Periodicals, Inc.
引用
收藏
页码：337 / 344
页数：8
相关论文
共 50 条
  • [41] Impact of worsening renal function during the treatment of decompensated heart failure on changes in renal function during subsequent hospitalization
    Testani, Jeffrey M.
    Cappola, Thomas P.
    McCauley, Brian D.
    Chen, Jennifer
    Shen, James
    Shannon, Richard P.
    Kimmel, Stephen E.
    AMERICAN HEART JOURNAL, 2011, 161 (05) : 944 - 949
  • [42] Cancer treatment in childhood and testicular function: the importance of the somatic environment
    Stukenborg, Jan-Bernd
    Jahnukainen, Kirsi
    Hutka, Marsida
    Mitchell, Rod T.
    ENDOCRINE CONNECTIONS, 2018, 7 (02): : R69 - R87
  • [43] PHARMACOKINETICS OF CREATININE IN MAN AND ITS IMPLICATIONS IN MONITORING OF RENAL-FUNCTION AND IN DOSAGE REGIMEN MODIFICATIONS IN PATIENTS WITH RENAL-INSUFFICIENCY
    CHIOU, WL
    HSU, FH
    JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 15 (5-6): : 427 - 434
  • [44] Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications
    Lumahan, Lance Edward V.
    Arif, Mazia
    Whitener, Amy E.
    Yi, Ping
    CELLS, 2024, 13 (02)
  • [45] Renal function after treatment for childhood cancer: A report from the St. Jude Lifetime Cohort Study.
    Green, Daniel M.
    Wang, Mingjuan
    Krasin, Matthew J.
    Srivastava, Deokumar
    Howell, Carrie R.
    Jay, Dennis W.
    Ness, Kirsten K.
    Greene, William
    Lanctot, Jennifer Q.
    Shelton, Kyla C.
    Davidoff, Andrew M.
    Ehrhardt, Matthew J.
    Mulrooney, Daniel A.
    Robison, Leslie L.
    Hudson, Melissa M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [46] Monitoring of renal function in cancer patients:: an ongoing challenge for clinical practice
    Kleber, M.
    Cybulla, M.
    Bauchmueller, K.
    Ihorst, G.
    Koch, B.
    Engelhardt, M.
    ANNALS OF ONCOLOGY, 2007, 18 (05) : 950 - 958
  • [47] VIGILANT CARDIAC FUNCTION MONITORING IN CHILDHOOD CANCER SURVIVORS: A SPECIALIZED TEAM APPROACH
    Mueller, Emily
    Rivard, Linda
    Silver, Marc A.
    Cianci, Pamela
    Brennan, Sharon
    Salvi, Sharad
    Canner, Jason
    PEDIATRIC BLOOD & CANCER, 2011, 56 (06) : 939 - 939
  • [48] Acute liver and renal failure during treatment with buprenorphine at therapeutic dose
    Zuin, M.
    Giorgini, A.
    Selmi, C.
    Battezzati, P. M.
    Cocchi, C. A.
    Crosignani, A.
    Benetti, A.
    Invernizzi, P.
    Podda, M.
    DIGESTIVE AND LIVER DISEASE, 2009, 41 (07) : E8 - E10
  • [49] HEMOSTASIS MODIFICATIONS DURING INTERLEUKIN 2 THERAPY IN ADVANCED RENAL-CELL CANCER
    NEGRIER, C
    BORDET, JC
    DURBIN, S
    MERCATELLO, A
    TOGNET, E
    NEGNER, S
    PHILIP, T
    DECHAVANNE, M
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1055 - 1055
  • [50] RELATION BETWEEN THE DOSE DISTRIBUTION DURING CHILDHOOD CANCER RADIOTHERAPY AND THE RISK OF SECOND CANCER.
    Diallo, I.
    Girinsky, T.
    Lefkopoulos, D.
    Chavaudra, J.
    Tubiana, M.
    Bourhis, J.
    de Vathaire, F.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S38 - S39
12345